PURPOSE: The purpose of this study was to evaluate improvement in symptoms of fecal incontinence (FI) in a group of women who also had urinary incontinence (UI) and were successfully implanted with the sacral neuromodulation (SNM) device primarily for urinary incontinence in one US institution. METHODS: Twenty-four patients with FI and UI who failed to improve with conservative or standard surgical treatment underwent permanent SNM after a successful peripheral nerve stimulation test during 2003-2007. Wexner incontinence score, fecal incontinence quality of life (FIQL), and Bristol stool scales were recorded before and after treatment. Follow-up was done by questionnaires contact. RESULTS: Twenty-four patients (mean age 56.5 +/- 5.3 years) were studied. The median follow-up was 28 months (range 3-49). Twenty-two patients (92%) were contacted. Seven patients (31.8%) experienced improvement in both urinary and fecal incontinence symptoms. Twelve patients (54.5%) experienced no improvement in FI symptoms after SNM. Four patients required a colostomy or ileostomy; four had the system explanted (two, due to a faded clinical response and two, due to infection); and four other patients experienced no improvement after SNM. The outcomes of ten patients (45.5%) with functioning SNM were reviewed. There were significant improvement of FI symptoms with a significantly lower Wexner score from 12.0 +/- 2.0 before SNM to 4.7 +/- 3.6 (p = 0.009). The mean FIQL scores improved significantly from the baseline score 7.8 +/- 0.8 before SNM to 13.5 +/- 2.6 (p = 0.009). Bristol stool form scale was reduced significantly from 4.5 to 3.5 after SNM (p = 0.02). CONCLUSIONS: SNM may be beneficial in selected female patients with UI associated with FI. Prospective trials may help delineate which patients will show FI improvement in this combined group.
PURPOSE: The purpose of this study was to evaluate improvement in symptoms of fecal incontinence (FI) in a group of women who also had urinary incontinence (UI) and were successfully implanted with the sacral neuromodulation (SNM) device primarily for urinary incontinence in one US institution. METHODS: Twenty-four patients with FI and UI who failed to improve with conservative or standard surgical treatment underwent permanent SNM after a successful peripheral nerve stimulation test during 2003-2007. Wexner incontinence score, fecal incontinence quality of life (FIQL), and Bristol stool scales were recorded before and after treatment. Follow-up was done by questionnaires contact. RESULTS: Twenty-four patients (mean age 56.5 +/- 5.3 years) were studied. The median follow-up was 28 months (range 3-49). Twenty-two patients (92%) were contacted. Seven patients (31.8%) experienced improvement in both urinary and fecal incontinence symptoms. Twelve patients (54.5%) experienced no improvement in FI symptoms after SNM. Four patients required a colostomy or ileostomy; four had the system explanted (two, due to a faded clinical response and two, due to infection); and four other patients experienced no improvement after SNM. The outcomes of ten patients (45.5%) with functioning SNM were reviewed. There were significant improvement of FI symptoms with a significantly lower Wexner score from 12.0 +/- 2.0 before SNM to 4.7 +/- 3.6 (p = 0.009). The mean FIQL scores improved significantly from the baseline score 7.8 +/- 0.8 before SNM to 13.5 +/- 2.6 (p = 0.009). Bristol stool form scale was reduced significantly from 4.5 to 3.5 after SNM (p = 0.02). CONCLUSIONS:SNM may be beneficial in selected female patients with UI associated with FI. Prospective trials may help delineate which patients will show FI improvement in this combined group.
Authors: M Queralto; G Portier; P H Cabarrot; G Bonnaud; J P Chotard; M Nadrigny; F Lazorthes Journal: Int J Colorectal Dis Date: 2005-12-06 Impact factor: 2.571
Authors: Ozenç Uludağ; Sacha M P Koch; Wim G van Gemert; Cees H C Dejong; Cor G M I Baeten Journal: Dis Colon Rectum Date: 2004-08 Impact factor: 4.585
Authors: Michael E D Jarrett; Thomas C Dudding; R John Nicholls; Carolynne J Vaizey; C Richard G Cohen; Michael A Kamm Journal: Dis Colon Rectum Date: 2008-02-27 Impact factor: 4.585
Authors: Bradley C Gill; Mia A Swartz; Raymond R Rackley; Courtenay K Moore; Howard B Goldman; Sandip P Vasavada Journal: Int Urogynecol J Date: 2011-09-09 Impact factor: 2.894
Authors: Laura Alonso Guardo; Carlos Cano Gala; David Sánchez Poveda; Pablo Rueda Juan; Francisco José Sánchez Montero; José Carlos Garzón Sánchez; Juan Ignacio Santos Lamas; Miguel Vicente Sánchez Hernández Journal: Korean J Pain Date: 2016-01-04